US Stock MarketDetailed Quotes

THTX Theratechnologies

Watchlist
  • 1.7500
  • +0.1200+7.36%
Close Feb 14 16:00 ET
  • 1.7500
  • 0.00000.00%
Post 20:01 ET
80.47MMarket Cap-43.75P/E (TTM)

About Theratechnologies Company

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.

Company Profile

SymbolTHTX
Company NameTheratechnologies
Listing DateOct 10, 2019
Founded1993
CEOMr. Paul Levesque
MarketNASDAQ
Employees58
Fiscal Year Ends11-30
Address2015 Peel Street,11th floor
CityMontréal
ProvinceQuébec
CountryCanada
Zip CodeH3A 1T8
Phone1-514-336-7800

Company Executives

  • Name
  • Position
  • Salary
  • Paul Levesque
  • Director, President and Chief Executive Officer
  • 1.90M
  • Dr. Christian Marsolais, PhD
  • Senior Vice President and Chief Medical Officer
  • 656.79K
  • Philippe Dubuc
  • Senior Vice President and Chief Financial Officer
  • 654.50K
  • John Leasure
  • Global Commercial Officer
  • 604.30K
  • Marie-Noel Colussi
  • Vice President, Finance
  • --
  • Andre Dupras
  • Vice President, Human Resources
  • --
  • Dawn Svoronos
  • Chairman of the Board
  • 152.52K
  • Joseph P. Arena
  • Independent Director
  • 72.44K
  • Dale MacCandlish Weil
  • Independent Director
  • 77.74K
  • Gerald A. Lacoste
  • Independent Director
  • 83.67K
  • Frank A. Holler
  • Independent Director
  • 76.26K
  • Andrew T. Molson
  • Independent Director
  • 74.78K
  • Alain Trudeau
  • Independent Director
  • 83.67K
  • Jocelyn Lafond
  • General Counsel and Corporate Secretary
  • 468.88K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More